1 Min Read
June 29 (Reuters) - Myovant Sciences Ltd
* Myovant sciences ltd - initiates phase 3 clinical program of relugolix in women with endometriosis-associated pain Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.